Prokupets Elena's Form 4 filing
C4 Therapeutics, Inc. (CCCC) · filed Sep 21, 2021
- Accession no.
- 0001209191-21-057118
- Filed
- Sep 21, 2021
- Trade date
- Sep 17-21, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.06M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prokupets ElenaCIK 0001824823 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | SSaleDisposed | −5,152 | $50.04F2 | −$257,806.08 | 48,024 | Indirect | |
| Sep 17, 2021 | Common Stock | SSaleDisposed | −5,688 | $50.05F2 | −$284,684.4 | 531,697 | Indirect | |
| Sep 21, 2021 | Common Stock | SSaleDisposed | −4,988 | $50.13F5 | −$250,048.44 | 43,036 | Indirect | |
| Sep 21, 2021 | Common Stock | SSaleDisposed | −5,333 | $50.14F5 | −$267,396.62 | 526,364 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.